We Help Companies Find New Sales Opportunities
Chemicals & Pharmaceuticals - 2012
Altrika, the Sheffield-based biotechnology firm, has been sold by Ilika to Adiposet for £0.1m.
DCC Healthcare is to acquire Kent Pharma, the Ashford-based pharmaceuticals company with 304 staff, for £58m.
Valspar is setting up a new 7,800 sq ft headquarters for its paints business at the IQ Winnersh business park near Reading.
Scientific & Technical Gases is to set up a new £2m 10,000 sq ft manufacturing plant at a former Air Liquide site in Newcastle under Lyme by 2015, with the creation of 20 jobs.
LondonPharma is relocating its Norwich-based drug development business to the Norwich Research Park Innovation Centre.
TTS Pharma is to relocate its diagnostic blood test products business from Bristol to Liverpool Science Park in early 2013.
The University of Edinburgh is planning to build a new £40m biological sciences teaching and research centre.
Corin, the Cirencester-based orthopaedics manufacturer with 100 staff, is to be acquired by 2IL Orthopaedics of Italy for £30m.
AFC Energy has secured a £5m European grant to build an alkaline fuel cell system at the ICL chemical plant in Grays, Essex.
Queen's University Belfast has secured funding of £32m to set up a Centre for Experimental Medicine by 2016.
Luxfer is to invest £13m in the expansion of its Magnesium Elektron and MEL Chemicals production plants in Greater Manchester.
Selden has acquired the Jeyes Professional cleaning brand and will transfer production and ten jobs from Preston and Mold to Buxton.
AstraZeneca has secured government funding of £5m to help develop a BioScience cluster at its Alderley Edge research site, in order to attract innovative pharmaceutical companies.
Redx Pharma is to create 119 jobs at its Liverpool-based pharmaceuticals development business, as one of 130 projects to benefit from the government's £2.4bn Regional Growth Fund.
Wiltshire Council, Trebor Developments and Wrenbridge Land have secured a £10m government grant to build a £180m life sciences business park at Porton Down, with the creation of more than 2,000 jobs over the next ten years.
Yanco has acquired a 44,000 sq ft unit in south Liverpool for a new insecticide production facility.
Alliance Pharma has acquired Opus Group Holdings, the distributor of skin creams and cleansers, for £8m.
Amdipharm, the Essex-based pharmaceuticals marketing company, is to be acquired by private equity firm Cinven for £367m.
Infinergy Technology is seeking permission to build a £16m biotechnology-based power station at Ricall Business Park in Selby, with the creation of 36 jobs.
Victrex is to invest £90m in the development of a new PEEK polyaryletherketone production plant at its Hillhouse site in Lancashire by 2015.
Integrated Magnetic Systems is to set up a protein production facility at the Prospect Business Centre in Dundee.
SAFC is to set up a new powder manufacturing facility at its chemicals plant in Irvine, with the creation of 24 jobs.
Molplex is planning to expand its Newcastle-based drug discovery automation business with a new base in Liverpool or Manchester, having secured an investment from the North West Fund.
SNF Oil & Gas is seeking permission to set up a polyacrylamide emulsion manufacturing facility in Billingham by 2014, with the creation of 250 jobs.
Unilever is to proceed with plans for a new £40m manufacturing and IT hub for its personal care products at Port Sunlight, with the creation of 150 jobs.
Strathclyde Pharmaceuticals is to invest in additional facilities for its East Kilbride-based pharmaceutical wholesaling business, with the creation of 40 jobs.
Benchmark Holdings has acquired the Novartis Animal Health vaccines factory in Braintree for undisclosed terms.
Briar Chemicals is to invest in a new waste water treatment plant and production facility at its site in Norwich, following its acquisition by Aurelius.
York Potash has selected a site at Dove Nest Farm near Whitby as the preferred location for a new potash mine, with the creation of up to 5,000 jobs.
ACM Global Central Laboratory is to relocate its York-based clinical testing services business to a 14,000 sq ft office at The Edge later this year.
Christeyns UK has expanded its detergents and chemicals business with the acquisition of a 50% stake in Klenzan, the Warrington-based food hygiene firm, for undisclosed terms.
Medical Research Council is to provide £60m of funding for the expansion of the Institute of Genetics & Molecular Medicine at the University of Edinburgh over the next five years.
United Drug is to acquire the clinical services businesses of Bilcare for £39m, including 195 staff in South Wales and the US.
South Devon Healthcare NHS Foundation Trust is planning to set up a new 67,000 sq ft pharmaceutical manufacturing unit in Paignton, with the relocation of 85 staff from three existing sites.
Mercury Pharma, the London-based pharmaceuticals company, is to be acquired by private equity firm Cinven for £465m.
Oxford University has agreed a deal to acquire the Park Hospital site in Headington, in order to develop a new medical science centre with four laboratories and up to 3,000 staff.
GlaxoSmithKline has raised £172m from the sale of 25 Australian pharmaceutical brands to Aspen Pharmacare.
ICON Development Solutions is to set up a 40,000 sq ft Centre of Excellence for Translational Medicine at the Citylabs scheme in Manchester.
Versalis of Italy is to invest about £40m in the expansion of elastomer production capacity at its site in Grangemouth, with the creation of 20 jobs.
Alliance Pharma has acquired three anti-malarial brands from AstraZeneca for an initial £4.2m.
GlaxoSmithKline is to operate a new £10m medical science research centre at the Olympics testing laboratory in Harlow, with funding from the Medical Research Council and the Department of Health.
William Sinclair is to relocate its Lincoln-based horticultural business to a new site at New Bridge Road in Ellesmere Port over the next five years, with the creation of up to 250 jobs.
The Physiological Society is to relocate its London headquarters to the 8,100 sq ft Priory Court office on Farringdon Lane.
Huntsman is to invest £15m in the expansion of its titanium dioxide plant in Hartlepool by 2014, with the creation of 90 jobs.
Sanofi is planning to double the 40-strong workforce at its new Flutiform asthma inhaler production line at Holmes Chapel in Cheshire over the next two years.
Plant Impact is to relocate the headquarters of its biotechnology business from Preston to its Rothamsted research centre in Hertfordshire in September.
GlaxoSmithKline is to acquire US-based Human Genome Sciences for £1.9bn, in order to gain new treatments for lupus, diabetes and heart disease.
Cherwell Laboratories is planning to expand the 56-strong workforce at its Bicester-based environmental testing kits business by 20%.
Banner Chemicals has acquired KMZ Chemicals, the Northampton-based chemicals distributor, for undisclosed terms.
Redx Pharma is seeking government funding to set up a £11m superbug treatment research centre in Liverpool, with the creation of 119 jobs.
Gelicity UK is planning to double the 45-strong workforce at its Flint-based skincare business this year, and will relocate to a larger 18,500 sq ft site on the Castle Industrial Estate.
Forensic Access is to set up a new forensic science facility at Sand Hutton in North Yorkshire, and plans to double the 15-strong workforce.
Aesica is to create 100 new jobs at its Queenborough pharmaceuticals plant on the Isle of Sheppey over the next three years.
LifeScan is to invest £9.5m in the transfer of its blood glucose monitoring research operations to its main site in Inverness, securing 1,100 jobs and creating 19 new jobs.
University of Liverpool is to relocate 50 infectious disease researchers to an 8,000 sq ft laboratory and office at Liverpool Science Park from July.
Unilever is to invest £40m in the expansion of its Port Sunlight shampoo and soaps factory on Merseyside, with the creation of 150 jobs.
Proximagen, the biotechnology firm with 40 staff in London and Cambridge, is to be acquired by US-based Upsher-Smith for at least £223m.
GlaxoSmithKline is to buy the Toctino eczema treatment from Basilea of Switzerland for up to £200m, in order to expand its Stiefel dermatology business.
Whitford is to relocate its Runcorn-based coatings business and about 80 staff to a four-acre site nearby in August, with the creation of ten new jobs.
Nova Laboratories is to expand the 160-strong workforce at its Leicestershire-based pharmaceuticals business with an unspecified number of new jobs, having won approval for a new leukaemia treatment.
Invest in Nottingham is in discussions with an unnamed Indian pharmaceuticals company that is considering Nottingham, Liverpool and Kent as potential locations for a new UK headquarters.
Phoenix Medical Supplies is setting up an 8,000 sq ft office for its pharmaceutical wholesaling business at Priory Court in Preston Brook, Runcorn.
Vitrology, the Glasgow-based biotechnology firm with 38 staff, is to be acquired by SGS of Switzerland.
Arcis Biotechnology of Daresbury has acquired Altos Medical, the US developer cleaning products for hospitals, for £2.5m.
Allergan is reported to be seeking a suitable location in in the Thames Valley for a new 180,000 sq ft headquarters for its pharmaceuticals business.
Chime Communications has acquired a 51% stake in Harvey Walsh, the Cheshire-based provider of data services to the pharmaceutical industry and the NHS, for an initial £2.2m.
GlaxoSmithKline is to acquire Cellzome, the protein research firm with sites in Cambridge and Germany, for £61m.
Angel Biotechnology has acquired a 6,500 sq ft collagen manufacturing plant in Glasgow for £0.2m, in order to expand its new Angel Biomedical subsidiary.
Equateq, the Isle of Lewis-based manufacturer of pharmaceutical ingredients with about 50 staff, has been acquired by BASF of Germany for undisclosed terms.
Scientific & Technical Gases is to expand the 50-strong workforce at its Staffordshire-based gas manufacturing business with ten new jobs over the next year.
Focus Pharmaceuticals is setting up a 34,000 sq ft warehouse at the Hindley Green business park in Wigan.
Life Technologies is to build a new £12m biosciences production plant at its site in Glasgow by 2014, with the creation of 30 jobs.
AstraZeneca is to acquire Ardea Biosciences, the US pharmaceuticals firm, for £782m.
Pharmacells has bought the assets of Immunosolv, the Edinburgh-based biotechnology firm, out of liquidation.
Protega Coatings, the West Bromwich-based industrial paints manufacturer with 42 staff, has been sold out of administration by FRP Advisory to an unnamed company.
Cat Tech International, the North Lincolnshire-based provider of catalyst handling services, has undergone a management buy-out from Clean Harbors, with backing from Maven Capital Partners.
Bayer CropScience has sold its 114-acre manufacturing site in Norwich, which has 260 staff, to Aurelius of Germany for undisclosed terms.
Dechra Pharmaceuticals is to acquire Eurovet Animal Health, the Dutch veterinary pharmaceuticals supplier with a site in Cambridge, from AUV Holding for £112m.
Ingenza is to create up to 40 jobs at its new biotech laboratory at the Roslin BioCentre in Midlothian.
DBG has acquired TAG Medical, the Nottingham-based provider of medical equipment testing services, for undisclosed terms.
GlaxoSmithKline is to invest £500m in the expansion of its pharmaceutical manufacturing facilities in the UK, including a new £350m plant at Ulverston in Cumbria, with the creation of up to 1,000 jobs.
Whitford has acquired a 70,000 sq ft property at Manor Park in Runcorn to expand its fluoropolymer coatings production and warehouse operations.
Comma Oil & Chemicals, the Kent-based supplier of lubricants and additives with 215 staff, is to be acquired by Cosan Group of Brazil for £63m.
Hale Group, the Widnes-based chemicals supplier trading as Forward Chemicals and Rexodan International, has been acquired by Zep Inc of the US for undisclosed terms.
Moray Council has approved plans to build a £6.5m life sciences centre on the Moray College UHI campus in Elgin over the next year.
Penn Pharma is to invest £14m in the expansion of its Gwent-based pharmaceuticals business, including a new 15,000 sq ft tablet manufacturing unit.
Simcyp, the Sheffield-based drug development firm, has been sold by Fusion IP to Certara of the US for about £20m.
Bayer CropScience is to invest £10m in improvements to its site in Norwich by early 2013, including waste water facilities and computer control equipment.
P&L Systems of Knaresborough has acquired SX Environmental, the Southend-based pest control supplies firm, for undisclosed terms.
Xceleron has been sold in a pre-pack administration to a management team, and most of the 20 jobs at its York-based pharmaceutical development business will be lost as operations are transferred to the US.
Nexus Oncology, the Edinburgh-based cancer research firm with more than 120 staff, has been acquired by Ockham of the US for undisclosed terms.
Liz Earle is planning to expand its cosmetics production facility at the Ryde Business Park on the Isle of Wight, with the creation of 500 jobs.
Chime Communications is to acquire Succinct Communications, the provider of medical communications for prescription medicines, for an initial £2m.
Biotec Services International is planning to expand the workforce at its Bridgend-based clinical trials service from 39 to 55 over the next few months, having acquired 15,000 sq ft of additional space.
INX International of the US is to set up a 40,000 sq ft ink manufacturing unit at the Hareshill Distribution Park near Rochdale in 2013, with the relocation of 68 jobs from the Transpennine Trading Estate.
Babraham Institute has won permission to expand its life sciences research centre in Cambridgeshire with four new research buildings, which could create up to 400 jobs.
University of Liverpool and a number of partners have submitted plans for the development of the 70,000 sq ft Liverpool BioInnovation Centre at the proposed 2m sq ft BioCampus life sciences park.
BioCity and the Roslin BioCentre are to set up a science hub at the 23-acre former Merck site in Airdrie, with the creation of up to 500 jobs.
Imperial College London is submitting plans for a new 1m sq ft campus at White City, including a biomedical research facility, offices and a hotel.
Chemoxy International, the speciality chemicals manufacturer with 80 staff in Middlesbrough and Billingham, has undergone a management buy-out from Dow Chemical.
PZ Cussons is to acquire the Fudge hair care brand from Sabre Group of Australia for £25m.